Condition: B-Cell Non-Hodgkin Lymphoma · Sponsor: Aibin Liang，MD，Ph.D.
A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma.
This description comes directly from the study's public registry record.
Aibin Liang MD,Ph.D. · +86 21 6611 1019 · lab7182@tongji.edu.cn
Ping Li MD · +86 135 6418 1131 · lilyforever@126.com
Always discuss trial participation with your own doctor first.
| Shanghai Tongji Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06734871